Khalid A Mohamedali

2PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 11, 2025
GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth.

Khalid A Mohamedali, Brian Aguirre, Cheng-Hsiang Lu

|Aug 01, 2019
Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.

Lawrence H Cheung, Yunli Zhao, Ana Alvarez-Cienfuegos

Pageof 1